| Trial Watch: Toll-like receptor agonists in cancer immunotherapy M Smith, E García-Martínez, MR Pitter, J Fucikova, R Spisek, L Zitvogel, ... Oncoimmunology 7 (12), e1526250, 2018 | 233 | 2018 |
| DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathway D Sun, W Wang, F Guo, MR Pitter, W Du, S Wei, S Grove, L Vatan, Y Chen, ... Oncoimmunology 11 (1), 2052640, 2022 | 9 | 2022 |
| Uncovering the immunoregulatory function and therapeutic potential of the PD-1/PD-L1 axis in cancer MR Pitter, W Zou Cancer research 81 (20), 5141-5143, 2021 | 9 | 2021 |
| Voluntary inhalation of methamphetamine: a novel strategy for studying intake non-invasively C Juarez-Portilla, RD Kim, M Robotham, M Tariq, M Pitter, J LeSauter, ... Psychopharmacology 234, 739-747, 2017 | 8 | 2017 |
| Brain activity during methamphetamine anticipation in a non-invasive self-administration paradigm in mice C Juárez-Portilla, M Pitter, RD Kim, PY Patel, RA Ledesma, J LeSauter, ... Eneuro 5 (2), 2018 | 6 | 2018 |
| Trial watch: toll-like receptor agonists in cancer immunotherapy. Oncoimmunology 7: e1526250 M Smith, E Garcia-Martinez, MR Pitter, J Fucikova, R Spisek, L Zitvogel, ... | 6 | 2018 |
| Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance H Lin, K Tison, Y Du, P Kirchhoff, C Kim, W Wang, H Yang, M Pitter, J Yu, ... Cancer Cell 42 (12), 2032-2044. e6, 2024 | 3 | 2024 |
| PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages MR Pitter, I Kryczek, H Zhang, N Nagarsheth, H Xia, Z Wu, Y Tian, K Okla, ... Cell reports 43 (3), 2024 | 3 | 2024 |
| Clinical relevance of mortalin in ovarian cancer patients A Rajtak, A Czerwonka, M Pitter, J Kotarski, K Okła Cells 12 (5), 701, 2023 | 3 | 2023 |
| The Role of Peptidyl Arginine Deiminases in Regulating Anti-tumor Responses in Immune Cells M Pitter | | 2024 |
| PAD4 controls the anti-tumor response by fine-tuning IFNγ signaling in macrophages MR Pitter, H Zhang, N Nagarsheth, H Xia, I Kryczek, W Zou The Journal of Immunology 210 (1_Supplement), 167.04-167.04, 2023 | | 2023 |
| Clinical Relevance of Mortalin in Ovarian Cancer Patients. Cells 2023, 12, 701 A Rajtak, A Czerwonka, M Pitter, J Kotarski, K Okła | | 2023 |
| Regulatory T Cell Biology and Its Applications in Cancer Immunotherapy MR Pitter, W Zou Cancer Immunotherapy Principles and Practice 2, Chapter 39, 2021 | | 2021 |
